Management of UTI in an 89-Year-Old Female with Dementia and Multiple Comorbidities Referred for Hospice Care
For this 89-year-old female patient with dementia, multiple comorbidities, and a confirmed UTI with ESBL Proteus mirabilis who has been referred for hospice care, the most appropriate approach is to treat the UTI with targeted antibiotics while initiating hospice services to address her overall decline and provide comfort-focused care.
Assessment of Current Status
- The patient shows clear signs of progressive cognitive decline with disorientation to time, place, and situation, consistent with advancing dementia 1
- Laboratory findings confirm a significant UTI with ESBL Proteus mirabilis (>100,000 CFU/ml), cloudy urine, and pyuria 1
- The patient's frailty, multiple comorbidities, and recent referral for hospice care indicate she is in an advanced stage of illness 1
- Her withdrawn behavior, decreased oral intake, and increasing dependence for ADLs suggest overall clinical decline beyond just the UTI 2
Treatment Approach for UTI
Antibiotic Selection
- Treat the UTI with appropriate antibiotics based on susceptibility testing for the ESBL Proteus mirabilis 1
- Avoid fluoroquinolones like ciprofloxacin if the patient has used them in the past 6 months due to increased resistance risk 3
- Consider a 7-14 day course of antibiotics, as UTIs in elderly patients with comorbidities should be treated as complicated infections 3
- Simplified medication regimens are recommended to reduce risk of adverse effects and medication errors 1
Monitoring Response
- Monitor for clinical response within 48-72 hours of initiating therapy 3
- Assess for resolution of suprapubic pressure and any improvement in mental status 1
- Consider follow-up urine culture after treatment completion to ensure eradication of the organism 3
Hospice Care Integration
- The patient's overall clinical picture (advanced dementia, frailty, multiple comorbidities, declining function) supports the referral for hospice services 2
- Hospice is appropriate for patients with a prognosis of 6 months or less and focuses on maximizing comfort and quality of life 2
- Hospice care should address both the patient's and family's needs through a team-based approach 4
- The hospice team should develop a comprehensive care plan addressing:
Medication Management
- Review all current medications and discontinue those with limited benefit given her prognosis 1
- Consider discontinuing medications for hyperlipidemia as the time horizon to benefit likely exceeds remaining life expectancy 1
- Maintain medications for symptom management (pain, anxiety) 1
- Simplify medication regimens to reduce burden and risk of adverse effects 1
- For atrial fibrillation management, weigh stroke prevention benefits against bleeding risks in the context of limited life expectancy 1
Communication and Decision-Making
- Engage the out-of-state POA in discussions about goals of care 1
- Document advance care preferences and ensure they are accessible to all care providers 1
- Discuss the benefits and burdens of various interventions in the context of the patient's overall prognosis 1
- Recognize that treatment decisions should be framed within the context of the patient's remaining life expectancy, functional status, and quality of life 1
Common Pitfalls to Avoid
- Avoid undertreating the UTI despite hospice status, as untreated UTIs in people with dementia are associated with high mortality (5.4% within 60 days) 5
- Avoid excessive diagnostic testing that would not change management or improve quality of life 1
- Do not continue unnecessary medications that offer minimal benefit given the limited life expectancy 1
- Avoid misinterpreting delirium from UTI as progression of dementia 1
- Recognize that UTI-related hematuria should resolve with appropriate antibiotic therapy; persistent hematuria would require further evaluation 6
By addressing both the acute UTI and initiating hospice care, this approach provides appropriate medical treatment while focusing on comfort and quality of life for this patient with advanced illness.